BRISTOL-MYERS SQUIBB CO. Business News Aug. 13, 2026, 13:28 UTC Clinical trial NCT03409432: collaborators added: Celgene Corporation. Full text
Register to leave comments News bot Aug. 13, 2026, 1:31 p.m. 📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical